Myosteatosis in Oeso-gastric Cancer: Clinical Impacts

Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · May 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how fat cells, known as adipocytes, might affect patients with esophageal and gastric cancers. Researchers want to understand the relationship between these fat cells and a condition called myosteatosis, which is when muscle tissue is replaced by fat. The study will look at medical images and collect samples from patients to analyze their body composition and how it relates to their cancer outcomes. This research aims to find out more about how these fat cells interact with muscle and tumors, which could help identify new treatments in the future.

To be eligible for this trial, participants must be adults over 18 years old who have been diagnosed with cancer of the esophagus, oeso-gastric junction, or stomach, and expected to survive for more than three months. They need to provide signed consent to participate. However, individuals with certain conditions like neuromuscular disorders, cognitive issues, or those who cannot communicate in French or English cannot join. Participants can expect to undergo tests and provide biological samples, which will help researchers learn more about cancer and improve treatment options for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with cancer of the oesophagus, oeso-gastric junction or stomach
• • Treatment and estimated survival of more than 3 months
• • Signed informed consent
• • \> 18 years of age
• Exclusion Criteria:
• • Neuromuscular or orthopedic pathology
• • Cognitive disorders
• • Psychiatric disorders
• • Inability to communicate in French or English

Trial Officials